Dr. Ayano Okuda of Shonan Beauty Clinic Shinjuku Main Branch Presents Research Findings at International Medical Conference “ASLS Bangkok 2026”

Sharing the latest insights in femcare and the potential applications of polynucleotides (PN) with the world

IRVINE, Calif. --SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced that Dr. Ayano Okuda of Shonan Beauty Clinic Shinjuku Main Branch, a clinic that receives management support from the Company, presented research findings at the international medical conference “ASLS Bangkok 2026,” held in Bangkok, Thailand, on September 2 and 3, 2026.

ASLS (Aesthetic Surgery & Laser Society) is an international medical conference originating from South Korea that brings together experts across a wide range of aesthetic healthcare fields, including aesthetic dermatology and aesthetic surgery, to share cutting-edge clinical insights and techniques. At “ASLS Bangkok 2026,” Dr. Okuda reported her clinical experience and latest findings on applying polynucleotides (PN)*, which have mainly been used in facial treatments, to aesthetic gynecology. She also engaged in active discussions with doctors, researchers, and other participants from many countries.

*Polynucleotides (PN): High-molecular-weight components derived from salmon DNA. With a viscous, three-dimensional structure, they are thought to act as a scaffold that supports tissue within the skin, and are used in injectable treatments aimed at improving skin texture and firmness.

As technological innovation continues to accelerate in the field of aesthetic healthcare, the importance of knowledge sharing and academic collaboration, beyond the clinical setting alone, has grown considerably. Meeting the increasingly diverse needs of customers requires not only the adoption of advanced techniques, but also broad perspectives and flexible thinking. SBC Medical remains committed to advancing cutting-edge initiatives through academic activities and international exchanges with research institutions, and to upholding the safety, transparency, and enduring value of aesthetic healthcare.

Overview of “ASLS Bangkok 2026”
Venue: Avani+ Riverside Bangkok Hotel (Bangkok, Thailand)
Dates: September 2 (Wed) and 3 (Thu), 2026
Official website: https://asls-bangkok.com/index.php

Presentation Title
“Beyond the Face: DOT™ Polynucleotides for Female Genital Rejuvenation”

About Dr. Ayano Okuda
After graduating from the School of Medicine at Kumamoto University, Dr. Okuda trained at Japanese Red Cross Kumamoto Hospital and Kumamoto University Hospital before joining Shonan Beauty Clinic in 2023. Specializing in aesthetic gynecology, she offers a broad range of approaches, from laser-based treatments and injectables to surgery, tailored to each customer’s wishes and condition. With the aim of supporting each person in being true to themselves, she makes recommendations only after careful, in-depth counseling. Through research presentations at conferences in Japan and overseas, she also contributes to improving the technical standards and safety of aesthetic healthcare.
For more information on Dr. Okuda’s professional profile, please visit here.

About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.

Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp